1. Home
  2. UAMY vs DBVT Comparison

UAMY vs DBVT Comparison

Compare UAMY & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UAMY
  • DBVT
  • Stock Information
  • Founded
  • UAMY 1968
  • DBVT 2002
  • Country
  • UAMY United States
  • DBVT France
  • Employees
  • UAMY N/A
  • DBVT N/A
  • Industry
  • UAMY Metal Fabrications
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UAMY Industrials
  • DBVT Health Care
  • Exchange
  • UAMY Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • UAMY 67.5M
  • DBVT 67.8M
  • IPO Year
  • UAMY N/A
  • DBVT N/A
  • Fundamental
  • Price
  • UAMY $0.69
  • DBVT $0.72
  • Analyst Decision
  • UAMY
  • DBVT Strong Buy
  • Analyst Count
  • UAMY 0
  • DBVT 2
  • Target Price
  • UAMY N/A
  • DBVT $5.00
  • AVG Volume (30 Days)
  • UAMY 853.0K
  • DBVT 52.4K
  • Earning Date
  • UAMY 11-11-2024
  • DBVT 10-29-2024
  • Dividend Yield
  • UAMY N/A
  • DBVT N/A
  • EPS Growth
  • UAMY N/A
  • DBVT N/A
  • EPS
  • UAMY N/A
  • DBVT N/A
  • Revenue
  • UAMY $9,862,364.00
  • DBVT $13,814,000.00
  • Revenue This Year
  • UAMY N/A
  • DBVT N/A
  • Revenue Next Year
  • UAMY N/A
  • DBVT $1,258.14
  • P/E Ratio
  • UAMY N/A
  • DBVT N/A
  • Revenue Growth
  • UAMY 18.08
  • DBVT 163.02
  • 52 Week Low
  • UAMY $0.17
  • DBVT $0.50
  • 52 Week High
  • UAMY $0.82
  • DBVT $2.28
  • Technical
  • Relative Strength Index (RSI)
  • UAMY 48.42
  • DBVT 48.83
  • Support Level
  • UAMY $0.67
  • DBVT $0.68
  • Resistance Level
  • UAMY $0.74
  • DBVT $0.73
  • Average True Range (ATR)
  • UAMY 0.06
  • DBVT 0.04
  • MACD
  • UAMY -0.01
  • DBVT 0.01
  • Stochastic Oscillator
  • UAMY 16.52
  • DBVT 78.57

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

Share on Social Networks: